Temporal and Demographic Variations in Hospital‐Based Influenza A Virus Positivity Rates Before, During, and After the COVID‐19 Pandemic: A 6‐Year Single‐Center Study in Southwest China
Immunity, Inflammation and Disease · 2026-11 · 14 (11)
DOI: 10.1002/iid3.70605 ↗Abstract
ABSTRACT Objective To characterize the epidemiological dynamics of hospital‐based influenza A virus (IAV) test positivity rates (TPR) across the pre‐, during‐, and post‐COVID‐19 pandemic periods in Southwest China, while addressing biases introduced by evolving testing methodologies and healthcare‐seeking behaviors. Methods A total of 57,704 influenza A test records from a symptom‐driven, care‐seeking population at the Third Hospital of Mianyang were retrospectively analyzed from 2018 to 2024. Detection methods included colloidal gold immunoassay (Stages 1–2) and quantitative PCR (Stage 3). Because assay type was completely confounded with pandemic stage, test‐performance comparisons across modalities were not feasible; all findings are interpreted as hospital‐based TPR rather than community prevalence. Results The overall IAV TPR was 14.8%. TPR dropped sharply to 4.5% during the implementation of non‐pharmaceutical interventions (NPIs) and surged to 17.8% in the post‐pandemic period, peaking in 2023. Age‐specific positivity patterns shifted markedly across stages, consistent with a composite of changing viral circulation, testing thresholds, and clinical triage practices. Conclusion IAV test positivity rebounded significantly following the relaxation of containment measures. Interpretations of TPR must account for detection‐method biases, variations in testing volume, and clinical triage practices, as TPR is a proxy for healthcare system stress rather than a direct measure of community prevalence. Stage‐specific, methodologically transparent surveillance is warranted to inform future pandemic preparedness.
EUVIMED